KalVista Pharmaceuticals, Inc. (KALV)
26.71
-0.01
(-0.04%)
USD |
NASDAQ |
May 07, 16:00
26.71
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals EPS Diluted (Quarterly) : -0.1055 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Tango Therapeutics, Inc. | -0.2945 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.372M |
| Revenue (Quarterly) | 59.92M |
| Total Expenses (Quarterly) | 65.30M |
| Enterprise Value | 1.405B |
| Gross Profit Margin (Quarterly) | 93.36% |
| Profit Margin (Quarterly) | -8.96% |
| Earnings Yield | -11.97% |
| Normalized Earnings Yield | -11.79 |